8401 - 8410 of 8587 Results
Title
Year
- Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonism2024OPENTitle: Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonismJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03506-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03506-xCitation Count: 1
- Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor2015OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: http://doi.org/10.1021/acsmedchemlett.5b00064Citation Count: 50
- Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment2024OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
- Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling2023OPENTitle: Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signallingJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 9Start Page: 3676End Page: 3689Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad162Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad162/50350389/awad162.pdfCitation Count: 13
- Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease2016OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
- Structure–Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists2022RESTRICTEDTitle: Structure–Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor AgonistsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1818End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00235Citation Count: 3
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 80
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/111216027/The_role_of_phosphodiesterase_WILSON_Accepted18February2019_GREEN_AAM.pdfCitation Count: 15
- Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study2021OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
-
OPENTitle: New Developments in Cholinergic Imaging in Alzheimer and Lewy Body DisordersJournal Name: Current Behavioral Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40473-020-00221-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7992054Citation Count: 8